MedTrace Logo

A Scalp Lotion Toimprove Sensitive Scalp Syndrome

NCT05630027 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-11-29

No results posted yet for this study

Summary

Overall, 100 Caucasian subjects participated in this 6-weeks lasting study, AC5+ was applied daily. All subjects had clinically confirmed mild to moderate alopecia and self-declared sensitive scalp. Instrumental assessments included Trans Epidermal Water Loss (TEWL), inflammation markers, clinical assessments included the severity of erythema, inflammation and greasiness. Subjective/Self assessments comprised the intensity of the scalp itch/pruritus and the evaluation of their head hair status (volume, abundance, strength). Same assessments were provided by the investigators.

Conditions

Interventions

OTHER

Piroctone Olamine (PO), 2,4 Diaminopyrimidine oxide (2.4 DA) and Vichy mineralizing water

observational, prospective study

Sponsors & Collaborators

  • Cosmetique Active International

    lead INDUSTRY

Principal Investigators

  • Philippe Massiot · L'OREAL Research and Innovation, Saint-Ouen, France

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-02
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05630027 on ClinicalTrials.gov